Lajos Pusztai

Yale University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (26)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (19)

Yesim Gokmen-Polar

Associate Professor

Emory University

UNITED STATES

View details

Christos Sotiriou

Université libre de Bruxelles

BELGIUM

View details

Yuval Kluger

Yale University

UNITED STATES

View details

Vincent Cannataro

Assistant Professor

Emmanuel College

UNITED STATES

View details

Emily Dolce

University of Michigan

UNITED STATES

View details

Mariana Chavez Mac Gregor

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Lisa Anne Carey

University of North Carolina at Chapel Hill

UNITED STATES

View details

Ciao-Sin Chen

University of Michigan

UNITED STATES

View details

Matthew Goetz

Professor of Oncology and Pharmacology

Mayo Clinic

UNITED STATES

View details

Sunil Badve

Vice Chair/ Professor

Emory University

UNITED STATES

View details

Thomas Karn

Goethe University Frankfurt

GERMANY

View details

Naureen Starling

Reader

Institute of Cancer Research

UNITED KINGDOM

View details

Shane Stecklein

University of Kansas Cancer Center

UNITED STATES

View details

Jeffrey Townsend

Elihu Professor of Biostatistics

Yale School of Public Health

UNITED STATES

View details

Giampaolo Bianchini

Head Breast Cancer Group

IRCCS Ospedale San Raffaele

ITALY

View details

Patricia Ganz

Professor

University of California, Los Angeles

UNITED STATES

View details

Andrew K. Godwin

University of Kansas Medical Center

UNITED STATES

View details

Mariya Rozenblit

Assistant Professor

Yale University

UNITED STATES

View details

N Lynn Henry

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lajos Pusztai

Research Interests

Explore related searches

Contact this professor

Articles (26)

Timing of Recurrence after Neoadjuvant Chemo-Immunotherapy in Patients with Early-Stage Triple-Negative Breast Cancer

ChatGPT Performance as Patient-Facing Triaging Tool in Oncology

Genomic landscape and homologous recombination repair deficiency signature in stage I-III and de novo stage IV primary breast cancers

Breastfeeding attributable fraction of triple negative breast cancer in the US

Clinical Management of Ovarian Function Suppression in Premenopausal Women With Breast Cancer: A Survey of Members of ASCO

Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor–Positive, Node-Positive Breast Cancer

Trends in breast cancer–specific death by clinical stage at diagnoses between 2000 and 2017

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer

Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer

Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221

Peripheral blood immune parameters, response, and adverse events after neoadjuvant chemotherapy plus durvalumab in early-stage triple-negative breast cancer

Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study

Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutations

Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay

Intratumor spatial heterogeneity in programmed death-ligand 1 (PD-L1) protein expression in early-stage breast cancer

De Novo Oligometastatic Breast Cancer

Systemic Staging of Locally Advanced Breast Cancer: How Hard to Look?

Incorporating clinicopathological and molecular risk prediction tools to improve outcomes in early HR+/HER2– breast cancer

Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay

Intratumour heterogeneity, from hypothesis to the clinic

Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer

Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy

Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency

Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors

Cancer Relevance of Human Genes

Collaborators (19)

Yesim Gokmen-Polar

Christos Sotiriou

Yuval Kluger

Vincent Cannataro

Emily Dolce

Mariana Chavez Mac Gregor

Lisa Anne Carey

Ciao-Sin Chen

Matthew Goetz

Sunil Badve

Thomas Karn

Naureen Starling

Shane Stecklein

Jeffrey Townsend

Giampaolo Bianchini

Patricia Ganz

Andrew K. Godwin

Mariya Rozenblit

N Lynn Henry

Make your next move.